Adaptive Biotechnologies (ADPT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ADPT Adaptive Biotechnologies

Watchlist

4.945
-0.115-2.27%

Trading Oct 31 14:12 ET

729.25MMarket Cap-3363P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Insiders At Adaptive Biotechnologies Sold US$626k In Stock, Alluding To Potential Weakness
Simply Wall StOct 31 09:05 ET
Goldman Sachs Initiates Adaptive Biotechnologies(ADPT.US) With Hold Rating, Announces Target Price $5.5
Moomoo NewsOct 15 02:31 ET · Ratings
Maintaining Hold on Adaptive Biotechnologies Amidst Gradual Market Adoption and Competitive Challenges
TipRanksOct 15 02:16 ET
Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024
Yahoo FinanceOct 9 16:05 ET
Adaptive Insurance Launches AI-Powered Platform For Climate Risks
BusinesswireOct 3 09:00 ET
Is Adaptive Biotechnologies (NASDAQ:ADPT) Using Too Much Debt?
Simply Wall StOct 3 08:28 ET

Comments

Jaguar8

Aug 29 07:03

NEWS

$Adaptive Biotechnologies (ADPT.US)$
Adaptive Announces IVDR Certification for clonoSEQ® in European Union
Adaptive Biotechnologies (Nasdaq: ADPT) has announced that its clonoSEQ® test has received In Vitro Diagnostic Regulation (IVDR) 2017/746 Class C certification in the European Union. This makes clonoSEQ the first IVDR-certified test for detecting minimal residual disease (MRD) in patients with lymphoid malignancies. The certification allows for broad use in assessing MRD status and chang...

TechWhiz

Jun 28 18:55

Good volume move up. Small caps like adaptive biotechnologies are moving after Nvidia and other big techs took a break.
Should see higher prices from here.

Trytosaveabit

May 31 06:39

Watching for data outa this!

$Adaptive Biotechnologies (ADPT.US)$ Adaptive Biotechnologies Says Its Next-generation Sequencing-based ClonoSEQ Test For Measurable Residual Disease Assessment Will Be Included In Several Oral And Poster Presentations At American Society Of Clinical Oncology Annual Meeting
The meeting will be taking place from May 31-June 4 in Chicago. Company will also present at the European Hematology Association (EHA) Hybrid Congress taking place June 13-16 in Madrid and virtually...

TechWhiz

May 4 08:24

Adaptive biotech earnings?

Will they be as good as Ardelyx? Hopefully.
Ardelyx price skyrocketed after good earnings. The tide could be turning for biopharm, biotech stocks.

Moomoo AI

Mar 8 04:26

Recent insider selling at Adaptive Biotechnologies and lack of insider buying in the past year may deter potential investors, despite insiders owning significant shares.

Have Adaptive Biotechnologies Insiders Been Selling Stock?

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

ADPT Adaptive Biotechnologies

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target